Author: user

[ad_1] By Aaditya GovindRao and Roushni Nair (Reuters) – Goodman Group’s stock has been on a hot streak this year, shining bright among its Australian real-estate peers as the artificial intelligence boom has driven a frenzied demand for data centres. Global “hyperscalers”, or large-scale cloud service providers, such as Amazon (NASDAQ:), Microsoft (NASDAQ:) and Meta (NASDAQ:), have been spending billions on data centres to cater to growing demand for AI services. Australia’s data-centre market, though nascent, saw outsized investment this year with Blackstone (NYSE:) buying AirTrunk for A$24 billion ($14.91 billion) in September and developer NEXTDC raising nearly A$4.6 billion…

Read More

[ad_1] Investing.com — Cabot gave its weekly top ten stock list, naming Kyndryl Holdings (NYSE:) its top pick given its attractive entry point. “As for the market, things finished up with a nice rally last Friday, but while certainly good to see, that doesn’t undo the action of the prior couple of weeks as a whole,” analyst wrote highlighting that many major indexes and growth measures had cracked their intermediate-term uptrends. Astera Labs: Riding the AI wave with its cutting-edge PCIe 6 switches, Astera is primed to dominate high-speed data transfer in cloud-scale environments. Birkenstock (NYSE:): The sandal giant leverages its…

Read More

[ad_1] Archer Aviation Inc. (NYSE:), a leading aircraft manufacturer with a market capitalization of $1.7 billion and an impressive 225% stock price surge over the past six months, has announced significant corporate changes following a special meeting of stockholders. The company has increased its authorized shares of Class A common stock from 700 million to 1.4 billion, as approved by stockholders on Monday. According to InvestingPro analysis, the stock currently trades at $11.18, near its 52-week high of $11.36. The San Jose-based company, previously known as Atlas (NYSE:) Crest Investment Corp., also made amendments to its bylaws and certificate of…

Read More

[ad_1] Ambarella Inc . (NASDAQ:), a semiconductor company with a market capitalization of $3.07 billion, has entered into a significant lease agreement, securing new executive offices in Santa Clara, California. According to InvestingPro data, the company maintains a strong financial position with more cash than debt and a healthy current ratio of 2.84. The lease, finalized on December 20, 2024, encompasses approximately 57,871 square feet of office space at 3001 Tasman Drive. The initial term of the lease is set for 104 months with an option for the company to renew for an additional five years. The lease commencement is…

Read More

[ad_1] (Reuters) – World leaders and U.S. politicians reacted to news that former U.S. President Jimmy Carter, who as president brokered peace between Israel and Egypt and later received the Nobel Peace Prize for his humanitarian work, has died at age 100. PRESIDENT JOE BIDEN AND FIRST LADY JILL BIDEN “Today, America and the world lost an extraordinary leader, statesman and humanitarian. Over six decades, we had the honor of calling Jimmy Carter a dear friend. But, what’s extraordinary about Jimmy Carter, though, is that millions of people throughout America and the world who never met him thought of him…

Read More

[ad_1] The Federal Reserve cut its target rate three times in late 2024, which means savings interest rates are falling from their historic highs. It’s important to be sure you’re getting the best rate possible when shopping around for a savings account. The following is a breakdown of savings interest rates today and where to find the best offers. The national average savings account rate stands at 0.42%, according to the FDIC. This might not seem like much, but consider that three years ago, it was just 0.06%, reflecting a sharp rise in a short period of time. Today, the…

Read More

[ad_1] How did the red wolf cross the road? With the help of a $25-million federal grant North Carolina received to build wildlife crossings, since car collisions are the species’ leading cause of death (Washington Post). It’s part of a $125-million effort that also helps Florida panthers, Maine moose and human beings (Forbes).Republicans generally oppose high-speed rail as “wasteful spending” in the abstract, but some Democratic supporters hope enough of them will change their minds if the routes run through red districts. (Roll Call)Road Bike Rider weighs in on the debate over taking the lane.Would automated traffic enforcement cameras help…

Read More

[ad_1] Former U.S. President Jimmy Carter holds up his Nobel Peace Prize Dec. 10, 2002, in Oslo, Norway. During his acceptance speech, Carter urged others to work for peace.Arne Knudsen | Getty Images News | Getty ImagesJimmy Carter, the Georgia peanut farmer who became a U.S. president and a Nobel Prize-winning activist for peace and human rights, has died. He was 100.Carter’s post-presidency had been widely seen as more successful than his time in the White House, and he called it “more gratifying.” even into his 90s, crusading for human rights, writing books, building homes for the needy with his…

Read More

[ad_1] New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DMC Global Inc. (NASDAQ: NASDAQ:) between May 3, 2024 and November 4, 2024, both dates inclusive (the “Class Period”), of the important February 4, 2025 lead plaintiff deadline. SO WHAT: If you purchased DMC Global securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the DMC Global class action, go to…

Read More

[ad_1] MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX250-CDx (Zircaix ®1, 89Zr- girentuximab) kidney cancer imaging2. TLX250-CDx is an investigational PET3 drug product for the non-invasive diagnosis and characterization of clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer. If approved, TLX250-CDx will be the first and only targeted PET agent specifically for kidney cancer to be commercially available…

Read More